Acorah Software Products - Accounts Production 19.1.200 false true false true No description of principal activity 2 August 2024 31 August 2025 31 August 2025 15872925 Mr Bhaval Patel Mr Sukhjeevan Jandu iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15872925 2024-08-01 15872925 2025-08-31 15872925 2024-08-02 2025-08-31 15872925 frs-core:CurrentFinancialInstruments 2025-08-31 15872925 frs-core:Non-currentFinancialInstruments 2025-08-31 15872925 frs-bus:PrivateLimitedCompanyLtd 2024-08-02 2025-08-31 15872925 frs-bus:FilletedAccounts 2024-08-02 2025-08-31 15872925 frs-bus:Micro-entities 2024-08-02 2025-08-31 15872925 frs-bus:AuditExempt-NoAccountantsReport 2024-08-02 2025-08-31 15872925 frs-bus:Director1 2024-08-02 2025-08-31 15872925 frs-bus:Director2 2024-08-02 2025-08-31
Registered number: 15872925
JPP Pharma Limited
Financial Statements
For the Period 2 August 2024 to 31 August 2025
Balance Sheet
Registered number: 15872925
31 August 2025
£
Fixed assets 446,663
Current assets 198,209
Creditors: Amounts Falling Due Within One Year (279,806 )
NET CURRENT LIABILITIES (81,597 )
TOTAL ASSETS LESS CURRENT LIABILITIES 365,066
Creditors: Amounts Falling Due After More Than One Year (308,979 )
NET ASSETS 56,087
CAPITAL AND RESERVES 56,087

Notes

1. General Information
JPP Pharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15872925 . The registered office is 80 High Street, Milton Regis, Sittingbourne, Kent, ME10 2AN.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Sukhjeevan Jandu
Director
24 February 2026